Zobrazeno 1 - 10
of 149
pro vyhledávání: '"M.F. Aillaud"'
Publikováno v:
Clinical Hemorheology and Microcirculation. 4:455-459
Autor:
M. Billerey, G.S. Lucas, M.W. Kenny, I. Juhan-Vague, M.F. Aillaud, John Stuart, M. Meakin, N.M. Caldwell
Publikováno v:
Clinical Hemorheology and Microcirculation. 3:451-467
Autor:
Pierre Morange, Marie-Christine Alessi, M. C. Barthet, Sophie Bouvet, William Cohen, David-Alexandre Trégouët, Christel Castelli, Pierre Suchon, Dominique Brunet, M.F. Aillaud
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 12(2)
Summary Background Although predicting the risk of venous thrombosis (VT) in an individual from a family with inherited thrombophilia is of major importance, it is often not feasible. Objectives To develop a simple risk assessment model that improves
Autor:
M.F. Aillaud, Irène Juhan-Vague, M. Grimaux, J. F. Renucci, Marie-Aline Charles, P.E. Morange, F. Giraud
Publikováno v:
Thrombosis and Haemostasis. 85:999-1003
SummaryFree-TFPI (f-TFPI) presents high anticoagulant activity and its plasma level correlates with unfavorable outcomes in unstable angina. Total TFPI (t-TFPI) represents mainly the lipid-bound form which seems to have a poor anticoagulant activity.
Autor:
Steve Kitchen, C. Vergnes, M. Johnston, C. Droullé, M.F. Aillaud, L. L. Houbouyan, Armando Tripodi, A. M. H. P. Van Den Besselaar, Tomas L. Lindahl, K. W. E. Denson, Marta Martinuzzo, M. Marren
Publikováno v:
Thrombosis and Haemostasis. 81:66-70
SummaryFive tissue factor reagents and three types of automated instruments for prothrombin time (PT) determination were studied in an international multicenter collaborative exercise. The purpose of this work was to determine the international sensi
Autor:
A. M. H. P. Van Den Besselaar, Steve Kitchen, Armando Tripodi, M.F. Aillaud, M. Marren, L. L. Houbouyan-Reveillard, C. Vergnes, Marta Martinuzzo, K. W. E. Denson, Tomas L. Lindahl, M. Johnston, C. Droullé
Publikováno v:
Thrombosis and Haemostasis. 82:1451-1455
SummaryThe interlaboratory variation of the International Normalized Ratio (INR) in various external quality assessment schemes is still relatively high. This is partly caused by inaccuracy of manufacturers’ stated International Sensitivity Index (
Autor:
Alun Evans, Irène Juhan-Vague, Dominique Arveiler, M.F. Aillaud, P. Amouyel, G. Luc, Jean Ferrières, Pierre Y. Scarabin
Publikováno v:
Scopus-Elsevier
SummaryThe contribution of coagulation factors and fibrinolytic variables to the development of ischaemic arterial disease is still not clearly established. The PRIME study is a prospective cohort study of myocardial infarction in men aged 50-59 year
Autor:
Marie-Christine Alessi, M.F. Aillaud, Anne Lise Alloin, Pierre-Emmanuel Morange, Hervé Chambost, Claire Oudin, Agathe Henneuse, Corinne Frere, Céline Falaise
Publikováno v:
Revue d'Oncologie Hématologie Pédiatrique. 2:211-212
Contexte Nous rapportons la demarche diagnostique d’un syndrome hemorragique chez une fille âgee de 6 ans. Observation Une fillette de 6 ans est hospitalisee pour volumineux hematome traumatique (torsion de l’avant bras par jeu). Elle n’a pas
Autor:
M.F. Aillaud, Jean-Noël Fiessinger, Berruyer M, Martine Alhenc-Gelas, P Priollet, Garcin Jm, Joseph Emmerich, Martine Aiach, Martine Wolf, Vallantin X, de Moerloose P, Brigitte Jude, Irène Juhan-Vague, Le Querrec A, Marie Dreyfus
Publikováno v:
Thrombosis and Haemostasis. 77:620-623
SummaryWe analyzed the clinical features of 36 patients homozygous for the Arg 506 to Gin factor V mutation and found a circumstantial event at risk for thrombosis in 29 of the 31 patients with thrombosis. The most frequent predisposing factors were
Autor:
L. Bendelac, A. Parquet, Y. Laurian, Edith Fressinaud, A. Derlon, M.F. Aillaud, M.A. Bertrand, B. Boneu, F. Verroust, A.M. Berthier, Jeanne-Yvonne Borg, Marie-Francoise Torchet, C. Guerois, M. Fiks-Sigaud, E. Subtil
Publikováno v:
Vox Sanguinis. 64:210-214
The levels of anti-human and anti-porcine factor VIII inhibitors, measured in 63 severe haemophilia A patients, lay in the ranges of < 0.2-2,600 and < 0.2-1,300 Bethesda units per ml (BU/ml), respectively, with a median cross-reactivity of 33%. In 4